MUSTANG BIO, INC. Other Receivables
MUSTANG BIO, INC. (MBIO) had Other Receivables of $217.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Notes › Nontrade Receivables
us-gaap:OtherReceivables · last filed 2025-11-07
- 2025-09-30: Other Receivables $217.00K.
- 2025-06-30: Other Receivables $217.00K.
- 2025-03-31: Other Receivables $467.00K.
- 2024-12-31: Other Receivables $402.00K.
| Period end | Other Receivables |
|---|---|
| 2025-09-30 | $217.00K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $217.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $467.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $402.00K 10-Q · filed 2025-11-07 |
| 2024-09-30 | $237.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $728.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $6.74M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $3.88M 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 |
| 2022-12-31 | $36.00K 10-Q · filed 2023-11-14 |
| 2022-09-30 | $33.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $33.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $32.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $50.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $41.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $32.00K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $17.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $15.00K 10-K · filed 2022-03-23 |
| 2020-09-30 | $37.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $25.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $14.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $19.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $55.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $128.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $111.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |